Literature DB >> 29430587

Preliminary experience with sofosbuvir-based treatment regimens for patients dependent on hemodialysis.

Rajiv Mehta1, Ketan Desai2, Mayank Kabrawala3, Subhash Nandwani3, Jatin Shah3, Nisha Desai2, Viral Parekh3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29430587     DOI： 10.1007/s12664-018-0833-1

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  10 in total

1.  Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.

Authors:  Varun Saxena; Farrukh M Koraishy; Meghan E Sise; Joseph K Lim; Monica Schmidt; Raymond T Chung; Annmarie Liapakis; David R Nelson; Michael W Fried; Norah A Terrault
Journal:  Liver Int       Date:  2016-03-24       Impact factor: 5.828

2.  Finally, safe and effective treatment options for hepatitis C in hemodialysis patients.

Authors:  Kalyan Ram Bhamidimarri; Paul Martin
Journal:  J Hepatol       Date:  2016-04-09       Impact factor: 25.083

3.  Efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C patients on dialysis.

Authors:  Narendra S Choudhary; Amit Kumar; Vijay Bodh; Shyam Bihari Bansal; Reetesh Sharma; Manish Jain; Sanjiv Saigal; Neeraj Saraf
Journal:  Indian J Gastroenterol       Date:  2017-03-09

4.  Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.

Authors:  Mohammed Shujauddin Akhil; Balaji Kirushnan; Melvin Martin; Kanakaraj Arumugam; N K Ganesh Prasad; Rajan Ravichandran
Journal:  Nephrology (Carlton)       Date:  2018-05       Impact factor: 2.506

5.  Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection.

Authors:  Sanjaya Kumar Satapathy; Chandra Sekhar Lingisetty; Susan Williams
Journal:  Hepatol Int       Date:  2011-06-23       Impact factor: 6.047

6.  The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.

Authors:  F Fabrizi; B Takkouche; G Lunghi; V Dixit; P Messa; P Martin
Journal:  J Viral Hepat       Date:  2007-10       Impact factor: 3.728

7.  Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.

Authors:  Aude Desnoyer; Dan Pospai; Minh Patrick Lê; Anne Gervais; Alexandra Heurgué-Berlot; Achour Laradi; Stanislas Harent; Adriana Pinto; Dominique Salmon; Sophie Hillaire; Hélène Fontaine; David Zucman; Anne-Marie Simonpoli; Patrice Muret; Lucile Larrouy; Brigitte Bernard Chabert; Diane Descamps; Yazdan Yazdanpanah; Gilles Peytavin
Journal:  J Hepatol       Date:  2016-03-04       Impact factor: 25.083

8.  Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Authors:  Paul J Pockros; K Rajender Reddy; Parvez S Mantry; Eric Cohen; Michael Bennett; Mark S Sulkowski; David E Bernstein; Daniel E Cohen; Nancy S Shulman; Deli Wang; Amit Khatri; Manal Abunimeh; Thomas Podsadecki; Eric Lawitz
Journal:  Gastroenterology       Date:  2016-03-11       Impact factor: 22.682

9.  Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.

Authors:  Eugene Kwon; Jang-Hee Cho; Hye Min Jang; Yon Su Kim; Shin-Wook Kang; Chul Woo Yang; Nam-Ho Kim; Hyun-Ji Kim; Jeung-Min Park; Ji-Eun Lee; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis.

Authors:  Jia-Jung Lee; Ming-Yen Lin; Jung-San Chang; Chi-Chih Hung; Jer-Ming Chang; Hung-Chun Chen; Ming-Lung Yu; Shang-Jyh Hwang
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240
  10 in total
  2 in total

1.  An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease.

Authors:  Sara Majd Jabbari; Khadije Maajani; Shahin Merat; Hossein Poustchi; Sadaf G Sepanlou
Journal:  PLoS One       Date:  2021-02-10       Impact factor: 3.240

2.  Efficacy and safety of sofosbuvir in the treatment of hep C among patients on hemodialysis: a systematic review and meta-analysis.

Authors:  Fadi Shehadeh; Markos Kalligeros; Katrina Byrd; Douglas Shemin; Eleftherios Mylonakis; Paul Martin; Erika M C D'Agata
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.